CAS 2803370-12-7

Fórmula: C38H42N10O4

InChI: InChI=1S/C38H42N10O4/c1-4-5-20-47-32-33(44(3)38(52)48(36(32)51)23-31-40-24(2)27-14-8-9-17-30(27)42-31)43-37(47)46-19-11-13-26(22-46)41-34(49)28-15-6-7-16-29(28)35(50)45-18-10-12-25(39)21-45/h6-9,14-17,25-26H,10-13,18-23,39H2,1-3H3,(H,41,49)/t25-,26-/m1/s1

Clave InChI: DGWJWWPYHJPRAZ-CLJLJLNGSA-N

SMILES: CC#CCN1C2=C(N=C1N3CCC[C@H](C3)NC(=O)C4=CC=CC=C4C(=O)N5CCC[C@H](C5)N)N(C(=O)N(C2=O)CC6=NC7=CC=CC=C7C(=N6)C)C

Linagliptin Related Compound E

CAS: 2803370-12-7

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Fórmula: C₃₈H₄₂N₁₀O₄

Forma y color: Beige Light Yellow Crystalline Powder

Peso molecular: 702.33905

Ref: 45-1366526

Linagliptin Impurity 50 HCl

CAS: 2803370-12-7

Fórmula: C₃₈H₄₂N₁₀O₄·HCl

Peso molecular: 702.82 36.46

Ref: 4Z-L-4463

Linagliptin EP Impurity E

CAS: 2803370-12-7

Fórmula: C₃₈H₄₂N₁₀O₄

Peso molecular: 702.82

Ref: ST-EA-CP-L1093

2-[(1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoic acid

CAS: 2803370-12-7

Pureza: 95%

Ref: IN-DA033FP1